BiVictriX Therapeutics' Seed VC Round

BiVictriX Therapeutics raised a round of funding on January 20, 2017.

BiVictriX Therapeutics (BVX) is a biotech company focused on developing and licensing novel, highly-selective, bispecific antibody drug conjugates (ADCs) to target unmet medical need in blood cancer. …

Articles about BiVictriX Therapeutics' Seed VC Round: